East China Pharmaceutical says weight-control drug application accepted
East China Pharmaceutical said its marketing authorization application for carvedilol tartrate tablets for long-term weight control in adults has been accepted.
Related stories
Compass Pathways Reports Quarterly Results for September 30 Quarter
M impact | EQUITY | Nov 03, 2026, 02:32 PM UTC
Marzetti Reports Quarterly Results for Quarter Ended September 30
M impact | EQUITY | Nov 03, 2026, 02:32 PM UTC
Stonepeak, Energy Equation Partners Acquire Stakes in Poland's Anwim
M impact | EQUITY | Nov 03, 2026, 02:32 PM UTC
Ardmore Shipping Reports Quarterly Results for Quarter Ended September 30
The headline reports results for the quarter ended September 30; the supplied body is truncated and provides no figures.
M impact | EQUITY | Nov 03, 2026, 02:32 PM UTC
Lincoln Private Market Index Rises 2.8% in Q3
The index rose 2.8% in Q3 as earnings growth persisted, while credit risks in private markets continued to surface.
M impact | EQUITY | Nov 03, 2026, 02:32 PM UTC
DigitalOcean shares fall 2.8% after Q3 results
M impact | EQUITY | Nov 03, 2026, 02:32 PM UTC